Literature DB >> 15575032

Rate of breast cancer diagnoses among postmenopausal women with self-reported breast symptoms.

Erin J Aiello1, Diana S M Buist, Emily White, Deborah Seger, Stephen H Taplin.   

Abstract

BACKGROUND: Breast cancer rates in women with multiple breast symptoms have not been well described.
METHODS: We examined the association between self-reported symptoms (lump, nipple discharge, pain, other) and breast cancer risk for screening and diagnostic mammograms in 57,681 women. Subanalyses evaluated risk among women with no prior mammograms, new symptoms, and repeated symptoms. One thousand, three hundred and eighty-nine women were diagnosed with cancer within 12 months of their mammograms. We calculated the breast cancer rate for each symptom and odds ratios (OR) with 95% confidence intervals (CI) for breast cancer among symptomatic women compared with asymptomatic women.
RESULTS: Women reporting a lump had an increased odds of breast cancer compared with asymptomatic women (OR for diagnostic examination = 2.8, 95% CI = 2.3 to 3.4; OR for screening examination = 3.6, 95% CI = 2.6 to 5.0). No other symptoms were associated with breast cancer after controlling for a reported lump. A new lump at a diagnostic examination was significantly predictive of cancer among women with no prior mammograms (OR = 12.2, 95% CI = 2.8 to 53.5); reporting symptoms at 2 successive exams had little effect on breast cancer risk (OR for lump = 1.2, 95% CI = 0.6 to 2.5).
CONCLUSIONS: Having a lump is the most predictive symptom of breast cancer whether it is reported at a screening or diagnostic examination or in conjunction with other symptoms.

Entities:  

Mesh:

Year:  2004        PMID: 15575032     DOI: 10.3122/jabfm.17.6.408

Source DB:  PubMed          Journal:  J Am Board Fam Pract        ISSN: 0893-8652


  9 in total

1.  Reported breast symptoms in the National Breast and Cervical Cancer Early Detection Program.

Authors:  A Blythe Ryerson; Jacqueline Miller; Christie R Eheman
Journal:  Cancer Causes Control       Date:  2015-03-10       Impact factor: 2.506

2.  Mastalgia-Cancer Relationship: A Prospective Study.

Authors:  Ali Cihat Yıldırım; Pınar Yıldız; Mustafa Yıldız; Şahin Kahramanca; Hülagü Kargıcı
Journal:  J Breast Health       Date:  2015-04-01

3.  Can breast ultrasound reduce patient's level of anxiety and pain?

Authors:  Fariba Zarei; Parisa Pishdad; Mohammad Hatami; Banafsheh Zeinali-Rafsanjani
Journal:  Ultrasound       Date:  2017-02-16

4.  History of benign breast disease and risk of breast cancer among women in China: a case-control study.

Authors:  Tsogzolmaa Dorjgochoo; Sandra L Deming; Yu-Tang Gao; Wei Lu; Ying Zheng; Zhixian Ruan; Wei Zheng; Xiao Ou Shu
Journal:  Cancer Causes Control       Date:  2008-03-18       Impact factor: 2.506

5.  Identifying suspected breast cancer: development and validation of a clinical prediction rule.

Authors:  Colin McCowan; Peter T Donnan; John Dewar; Alastair Thompson; Tom Fahey
Journal:  Br J Gen Pract       Date:  2011-05       Impact factor: 5.386

6.  Digital Mammography and Breast Tomosynthesis Performance in Women with a Personal History of Breast Cancer, 2007-2016.

Authors:  Janie M Lee; Laura E Ichikawa; Karen J Wernli; Erin Bowles; Jennifer M Specht; Karla Kerlikowske; Diana L Miglioretti; Kathryn P Lowry; Anna N A Tosteson; Natasha K Stout; Nehmat Houssami; Tracy Onega; Diana S M Buist
Journal:  Radiology       Date:  2021-05-18       Impact factor: 29.146

7.  Association of symptoms and breast cancer in population-based mammography screening in Finland.

Authors:  Deependra Singh; Nea Malila; Arun Pokhrel; Ahti Anttila
Journal:  Int J Cancer       Date:  2014-09-04       Impact factor: 7.396

8.  Can mastalgia be another somatic symptom in fibromyalgia syndrome?

Authors:  Meral Sen; Murat Ozgur Kilic; Ozlem Cemeroglu; Duygu Icen
Journal:  Clinics (Sao Paulo)       Date:  2015-11       Impact factor: 2.365

9.  Is it mastalgia or myofascial pain? A clinical confusion.

Authors:  Sibel Mandiroğlu; Ulvi Murat Yüksel; Sibel Ünsal Delialioğlu; Lütfi Doğan
Journal:  Arch Rheumatol       Date:  2021-01-14       Impact factor: 1.472

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.